These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
367 related items for PubMed ID: 21259244
1. ADAM 10 is associated with gastric cancer progression and prognosis of patients. Wang YY, Ye ZY, Li L, Zhao ZS, Shao QS, Tao HQ. J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244 [Abstract] [Full Text] [Related]
2. Upregulated expression of annexin II is a prognostic marker for patients with gastric cancer. Zhang Q, Ye Z, Yang Q, He X, Wang H, Zhao Z. World J Surg Oncol; 2012 Jun 08; 10():103. PubMed ID: 22681645 [Abstract] [Full Text] [Related]
3. Protein expression of HER2, 3, 4 in gastric cancer: correlation with clinical features and survival. He XX, Ding L, Lin Y, Shu M, Wen JM, Xue L. J Clin Pathol; 2015 May 08; 68(5):374-80. PubMed ID: 25731189 [Abstract] [Full Text] [Related]
4. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer. Wang YY, Ye ZY, Zhao ZS, Tao HQ, Chu YQ. Ann Surg Oncol; 2010 Jan 08; 17(1):89-97. PubMed ID: 19820999 [Abstract] [Full Text] [Related]
5. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T. J Clin Pathol; 2015 Oct 08; 68(10):795-801. PubMed ID: 26043748 [Abstract] [Full Text] [Related]
6. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival. Luo D, Huang H, Lu ML, Zhao GF, Chang J, Zheng MY, Wang Y. Pathol Oncol Res; 2012 Apr 08; 18(2):491-7. PubMed ID: 22109561 [Abstract] [Full Text] [Related]
7. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy. Aydin D, Bilici A, Yavuzer D, Kefeli U, Tan A, Ercelep O, Mert A, Yuksel S, Ozcelik M, Isik D, Surmeli H, Odabasi H, Aliustaoglu M. Clin Transl Oncol; 2015 Aug 08; 17(8):604-11. PubMed ID: 25786367 [Abstract] [Full Text] [Related]
8. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma. Tang P, Huang H, Chang J, Zhao GF, Lu ML, Wang Y. World J Gastroenterol; 2013 May 07; 19(17):2697-703. PubMed ID: 23674878 [Abstract] [Full Text] [Related]
9. Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma. Zhao P, Lu Y, Liu L. Int J Clin Exp Pathol; 2015 May 07; 8(5):5230-5. PubMed ID: 26191222 [Abstract] [Full Text] [Related]
10. [Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer]. Zhuge YH, Tao HQ, Wang YY. Zhonghua Yi Xue Za Zhi; 2011 Oct 25; 91(39):2765-8. PubMed ID: 22322056 [Abstract] [Full Text] [Related]
11. Should lymph node micrometastasis be considered in node staging for gastric cancer?: the significance of lymph node micrometastasis in gastric cancer. Lee CM, Cho JM, Jang YJ, Park SS, Park SH, Kim SJ, Mok YJ, Kim CS, Kim JH. Ann Surg Oncol; 2015 Mar 25; 22(3):765-71. PubMed ID: 25201506 [Abstract] [Full Text] [Related]
12. AKR1B10, a good prognostic indicator in gastric cancer. Yao HB, Xu Y, Chen LG, Guan TP, Ma YY, He XJ, Xia YJ, Tao HQ, Shao QS. Eur J Surg Oncol; 2014 Mar 25; 40(3):318-24. PubMed ID: 24406159 [Abstract] [Full Text] [Related]
13. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. Shun CT, Wu MS, Lin JT, Chen SY, Wang HP, Lee WJ, Wang TH, Chuang SM. Hepatogastroenterology; 1997 Mar 25; 44(14):604-9. PubMed ID: 9164544 [Abstract] [Full Text] [Related]
14. Overexpression of HER-2 Protein is a High-Risk Factor for Patients with Surgically-Resected Stage T3 Gastric Adenocarcinoma. Zhang Z, Wang B, Huang G, Wang R, Song J, Lin S, Wang W, Jiang Y, Huang Q, Wang L. Clin Lab; 2017 Jan 01; 63(1):115-125. PubMed ID: 28164509 [Abstract] [Full Text] [Related]
15. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Uchino S, Tsuda H, Maruyama K, Kinoshita T, Sasako M, Saito T, Kobayashi M, Hirohashi S. Cancer; 1993 Dec 01; 72(11):3179-84. PubMed ID: 7902202 [Abstract] [Full Text] [Related]
16. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors. Zhang L, Qiu M, Jin Y, Ji J, Li B, Wang X, Yan S, Xu R, Yang D. Int J Clin Exp Pathol; 2015 Dec 01; 8(9):11084-91. PubMed ID: 26617827 [Abstract] [Full Text] [Related]
17. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer. Jin C, Lin JR, Ma L, Song Y, Shi YX, Jiang P, Dong Y, Li XS. Oncotarget; 2017 Feb 07; 8(6):10416-10424. PubMed ID: 28060752 [Abstract] [Full Text] [Related]
20. Ezrin is associated with gastric cancer progression and prognosis. Li L, Wang YY, Zhao ZS, Ma J. Pathol Oncol Res; 2011 Dec 07; 17(4):909-15. PubMed ID: 21717114 [Abstract] [Full Text] [Related] Page: [Next] [New Search]